VACCINE ADJUVANT MARKET ANALYSIS

Vaccine Adjuvant Market, By Type (Mineral Salt-based Adjuvant, Tensoactive Adjuvants, Adjuvant Emulsions, Liposome Adjuvants, Carbohydrate Adjuvants, Bacteria-derived Adjuvants, Virus-like Particles (VLP), and Other Types), By Usage (Active Immunostimulants, Carriers, and Vehicle Adjuvants), By Disease Type (Infectious Disease and Cancer), By Application (Research Applications and Commercial Applications), and By Geography (North America, Europe, Asia Pacific, Middle East and Africa, and Rest of World)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Jan 2023
Code : CMI1731
Pages :169
Formats :
Excel and PDF
Industry : Pharmaceutical

Vaccine Adjuvant MarketSize and Trends

The global Vaccine Adjuvant Market was valued at US$ 1,430.0 Mn in 2021 and is forecast to reach a value of US$ 3,521.5 Mn by 2028 at a CAGR of 13.7% between 2022 and 2028.

Global Vaccine Adjuvant Market Trends:

Adjuvants such as aluminum salts are used as additives in vaccines to enhance immune responses. Aluminum salts include such as aluminum phosphate, aluminum potassium sulfate, and aluminum hydroxide. Furthermore, aluminum-based salts are also used for research purposes to enhance the effectiveness of vaccines. This trend is expected to continue during the forecast period, driving the growth of the global Vaccine Adjuvant Market.

Moreover, with the increase in burden of infectious diseases across the world, the usage of vaccine adjuvants is also increasing with a rapid pace. The prevalence of infectious diseases worldwide is increasing rapidly due to various factors, which in turn has increased the use of vaccine adjuvants as vaccination is one of the most efficient strategies for the prevention of infectious diseases. This trend is also expected to continue over the forecast period, driving the market growth.